dacarbazine and Anemia, Hemolytic, Acquired

dacarbazine has been researched along with Anemia, Hemolytic, Acquired in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardier, A; Blot, E; Decaudin, D; Pouillart, P; Veyradier, A; Zagame, OL1

Other Studies

1 other study(ies) available for dacarbazine and Anemia, Hemolytic, Acquired

ArticleYear
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
    Thrombosis research, 2002, Apr-15, Volume: 106, Issue:2

    Topics: ADAM Proteins; ADAMTS13 Protein; Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; CA-19-9 Antigen; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Esophageal Neoplasms; Fatal Outcome; Female; Humans; Ifosfamide; Jaundice; Metalloendopeptidases; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Paraneoplastic Syndromes; Sarcoma; Thrombocytopenia; von Willebrand Factor

2002